切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2022, Vol. 11 ›› Issue (02) : 149 -153. doi: 10.3877/cma.j.issn.2095-3224.2022.02.009

综述

直肠癌患者术后排尿功能障碍的危险因素研究进展
朱彤1, 董冠宏2, 刘桂娜2, 黄宇薇2, 汪晓东2,()   
  1. 1. 610041 成都,四川大学华西口腔医(学)院;610041 成都,四川大学华西医院胃肠外科
    2. 610041 成都,四川大学华西医院胃肠外科
  • 收稿日期:2021-08-23 出版日期:2022-04-25
  • 通信作者: 汪晓东
  • 基金资助:
    四川省卫生健康信息中心“卫生健康数字化发展”专项课题(2021ZXKY06003)

Research progress on risk factors of postoperative urinary dysfunction in patients with rectal cancer

Tong Zhu1, Guanhong Dong2, Guina Liu2, Yuwei Huang2, Xiaodong Wang2()   

  1. 1. West China School/Hospital of Stomatology, Sichuan University, Chengdu 610041, China; Department of Gastrointestinal Surgery, West China Hospital of Sichuan University, Chengdu 610041, China
    2. Department of Gastrointestinal Surgery, West China Hospital of Sichuan University, Chengdu 610041, China
  • Received:2021-08-23 Published:2022-04-25
  • Corresponding author: Xiaodong Wang
引用本文:

朱彤, 董冠宏, 刘桂娜, 黄宇薇, 汪晓东. 直肠癌患者术后排尿功能障碍的危险因素研究进展[J/OL]. 中华结直肠疾病电子杂志, 2022, 11(02): 149-153.

Tong Zhu, Guanhong Dong, Guina Liu, Yuwei Huang, Xiaodong Wang. Research progress on risk factors of postoperative urinary dysfunction in patients with rectal cancer[J/OL]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2022, 11(02): 149-153.

排尿功能障碍是直肠癌患者术后生存质量下降的重要因素之一,排尿功能障碍的类型及程度受多种因素影响,包括患者相关因素,如年龄、性别、肿瘤相关因素等;治疗相关因素,如手术术式、是否辅助放化疗等。现有研究从不同角度阐述了直肠癌患者术后排尿功能障碍发生的危险因素。本文通过回顾近年来关于直肠癌的手术治疗及术后生活质量研究的文献,总结患者相关因素和治疗相关因素对直肠癌患者术后排尿功能障碍的影响,以期全面阐明直肠癌术后患者排尿功能障碍可能存在的危险因素,有助于改进治疗措施来降低患者术后排尿功能障碍的发生率。

Micturition dysfunction is one of the important factors for the decline of postoperative quality of life in patients with rectal cancer. The type and degree of micturition dysfunction are affected by many factors, including patient related factors, such as age, gender, tumor related factors and treatment related factors, such as surgical procedure, whether adjuvant radiotherapy and chemotherapy or not, etc. Existing studies have expounded the risk factors of postoperative micturition dysfunction in patients with rectal cancer from different angles. By reviewing the literature on the surgical treatment and postoperative quality of life of rectal cancer in recent years, this paper summarizes the effects of patient related factors and treatment related factors on postoperative micturition dysfunction in patients with rectal cancer. In order to comprehensively clarify the possible risk factors of postoperative micturition dysfunction in patients with rectal cancer, it is helpful to improve treatment measures to reduce the incidence of postoperative urinary dysfunction.

[1]
Wani RA, Bhat IU, Parray FQ, et al. Quality of life after "Total Mesorectal Excision (TME)" for rectal carcinoma: a study from a Tertiary Care Hospital in Northern India[J]. Indian J Surg Oncol, 2017, 8(4): 499-505.
[2]
Veltcamp Helbach M, Koedam TWA, Knol JJ, et al. Quality of life after rectal cancer surgery: differences between laparoscopic and transanal total mesorectal excision[J]. Surg Endosc, 2019, 33(1): 79-87.
[3]
Karlsson L, Bock D, Asplund D, et al. Urinary dysfunction in patients with rectal cancer: a prospective cohort study[J]. Colorectal Dis, 2020, 22(1): 18-28.
[4]
Dulskas A, Samalavicius NE. A prospective study of sexual and urinary function before and after total mesorectal excision[J]. Int J Colorectal Dis, 2016, 31(6): 1125-1130.
[5]
Abdelli A, Tillou X, Alves A, et al. Genito-urinary sequelae after carcinological rectal resection: What to tell patients in 2017[J].J Visc Surg, 2017, 154(2): 93-104.
[6]
Beraldo FB, Yusuf SA, Palma RT, et al. Urinary dysfunction after surgical treatment for rectal cancer[J]. Arq Gastroenterol, 2015, 52(3): 180-185.
[7]
Cheung F, Sandhu JS. Voiding dysfunction after non-urologic pelvic surgery[J]. Curr Urol Rep, 2018, 19(9): 75.
[8]
Ito M, Kobayashi A, Fujita S, et al. Urinary dysfunction after rectal cancer surgery: Results from a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for clinical stage II or III lower rectal cancer (Japan Clinical Oncology Group Study, JCOG0212) [J]. Eur J Surg Oncol, 2018, 44(4): 463-468.
[9]
Hamamoto H, Yamamoto M, Masubuchi S, et al. Male sex and anterior wall tumor location as risk factors for urinary dysfunction after laparoscopic rectal surgery[J]. Surg Endosc, 2020, 34(8): 3567-3573.
[10]
Duran E, Tanriseven M, Ersoz N, et al. Urinary and sexual dysfunction rates and risk factors following rectal cancer surgery[J]. Int J Colorectal Dis, 2015, 30(11): 1547-1555.
[11]
Fernandez-Martinez D, Rodriguez-Infante A, Otero-Diez JL, et al. Is my life going to change?-a review of quality of life after rectal resection[J]. J Gastrointest Oncol, 2020, 11(1): 91-101.
[12]
Doeksen A, Gooszen JA, van Duijvendijk P, et al. Sexual and urinary functioning after rectal surgery: a prospective comparative study with a median follow-up of 8.5 years[J]. Int J Colorectal Dis, 2011, 26(12): 1549-1557.
[13]
Pocard M, Zinzindohoue F, Haab F, et al. A prospective study of sexual and urinary function before and after total mesorectal excision with autonomic nerve preservation for rectal cancer[J]. Surgery, 2002, 131(4): 368-372.
[14]
Uebersax JS, Wyman JF, Shumaker SA, et al. Short forms to assess life quality and symptom distress for urinary incontinence in women: the incontinence impact questionnaire and the urogenital distress inventory. continence program for women research group[J].Neurourol Urodyn, 1995, 14(2): 131-139.
[15]
Hur H, Bae SU, Kim NK, et al. Comparative study of voiding and male sexual function following open and laparoscopic total mesorectal excision in patients with rectal cancer[J]. J Surg Oncol, 2013, 108(8): 572-578.
[16]
Yamaoka Y, Kagawa H, Shiomi A, et al. Robotic-assisted surgery may be a useful approach to protect urinary function in the modern era of diverse surgical approaches for rectal cancer[J]. Surg Endosc, 2021, 35(3): 1317-1323.
[17]
Lange MM, van de Velde CJ. Urinary and sexual dysfunction after rectal cancer treatment[J]. Nat Rev Urol, 2011, 8(1): 51-57.
[18]
Ledebo A, Bock D, Prytz M, et al. Urogenital function 3 years after abdominoperineal excision for rectal cancer[J]. Colorectal Dis, 2018, 20(6): O123-O134.
[19]
Kwaan MR, Fan Y, Jarosek S, et al. Long-term risk of urinary adverse events in curatively treated patients with rectal cancer: a population-based analysis[J]. Dis Colon Rectum, 2017, 60(7): 682-690.
[20]
Sartori CA, Sartori A, Vigna S, et al. Urinary and sexual disorders after laparoscopic TME for rectal cancer in males[J]. J Gastrointest Surg, 2011, 15(4): 637-643.
[21]
McGlone ER, Khan O, Flashman K, et al. Urogenital function following laparoscopic and open rectal cancer resection: a comparative study[J]. Surg Endosc, 2012, 26(9): 2559-2565.
[22]
Zhao Y, Hou XL, Ding JH, et al. Early urinary dysfunction after laparoscopic rectal cancer surgery: does surgeons' learning curve matter? [J]. Am Surg, 2018, 84(5): 658-666.
[23]
Qiao Q, Che X, Li X, et al. Recovery of urinary functions after laparoscopic total mesorectal excision for T4 rectal cancer[J]. J Laparoendosc Adv Surg Tech A, 2016, 26(8): 614-617.
[24]
Shiraishi T, Ito M, Sasaki T, et al. Association between urinary function and resected pattern of the autonomic nerve system after transanal total mesorectal excision for rectal cancer[J]. Colorectal Dis, 2021, 23(2): 405-414.
[25]
Ma B, Gao P, Song Y, et al. Transanal total mesorectal excision (taTME) for rectal cancer: a systematic review and meta-analysis of oncological and perioperative outcomes compared with laparoscopic total mesorectal excision[J]. BMC Cancer, 2016, 16: 380.
[26]
Kowalewski KF, Seifert L, Ali S, et al. Functional outcomes after laparoscopic versus robotic-assisted rectal resection: a systematic review and meta-analysis[J]. Surg Endosc, 2021, 35(1): 81-95.
[27]
Yamaguchi T, Kinugasa Y, Shiomi A, et al. Robotic-assisted vs. conventional laparoscopic surgery for rectal cancer: short-term outcomes at a single center[J]. Surg Today, 2016, 46(8): 957-962.
[28]
Wee IJY, Kuo LJ, Ngu JC. Urological and sexual function after robotic and laparoscopic surgery for rectal cancer: A systematic review, meta-analysis and meta-regression[J]. Int J Med Robot, 2021, 17(1): 1-8.
[29]
Kim HJ, Choi GS, Park JS, et al. The impact of robotic surgery on quality of life, urinary and sexual function following total mesorectal excision for rectal cancer: a propensity score-matched analysis with laparoscopic surgery[J]. Colorectal Dis, 2018, 20(5): O103-O113.
[30]
Oshio H, Oshima Y, Yunome G, et al. Potential urinary function benefits of initial robotic surgery for rectal cancer in the introductory phase[J]. J Robot Surg, 2022, 16(1): 159-168.
[31]
Wang G, Wang Z, Jiang Z, et al. Male urinary and sexual function after robotic pelvic autonomic nerve-preserving surgery for rectal cancer[J].Int J Med Robot, 2017, 13(1): e1725.
[32]
Morelli L, Ceccarelli C, Di Franco G, et al. Sexual and urinary functions after robot-assisted versus pure laparoscopic total mesorectal excision for rectal cancer[J]. Int J Colorectal Dis, 2016, 31(4): 913-915.
[33]
Kim JY, Kim NK, Lee KY, et al. A comparative study of voiding and sexual function after total mesorectal excision with autonomic nerve preservation for rectal cancer: laparoscopic versus robotic surgery[J]. Ann Surg Oncol, 2012, 19(8): 2485-2493.
[34]
Luca F, Valvo M, Ghezzi TL, et al. Impact of robotic surgery on sexual and urinary functions after fully robotic nerve-sparing total mesorectal excision for rectal cancer[J]. Ann Surg, 2013, 257(4): 672-678.
[35]
Wang X, Qiu A, Liu X, et al. Total mesorectal excision plus lateral lymph node dissection vs TME on rectal cancer patients: a meta-analysis[J]. Int J Colorectal Dis, 2020, 35(6): 997-1006.
[36]
Hirata Y, Nozawa H, Kawai K, et al. The influence of neoadjuvant chemoradiation for lower rectal cancer on urinary function[J].Asian J Surg, 2019, 42(7): 731-739.
[37]
Huang M, Lin J, Yu X, et al. Erectile and urinary function in men with rectal cancer treated by neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy alone: a randomized trial report[J]. Int J Colorectal Dis, 2016, 31(7): 1349-1357.
[38]
Toritani K, Watanabe J, Suwa Y, et al. The risk factors for urinary dysfunction after autonomic nerve-preserving rectal cancer surgery: a multicenter retrospective study at Yokohama Clinical Oncology Group (YCOG1307) [J]. Int J Colorectal Dis, 2019, 34(10): 1697-1703.
[39]
Lee SY, Kang SB, Kim DW, et al. Risk factors and preventive measures for acute urinary retention after rectal cancer surgery[J].World J Surg, 2015, 39(1): 275-282.
[1] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[2] 吴晖, 佴永军, 施雪松, 魏晓为. 两种解剖入路下行直肠癌侧方淋巴结清扫的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 40-43.
[3] 周世振, 朱兴亚, 袁庆港, 刘理想, 王凯, 缪骥, 丁超, 汪灏, 管文贤. 吲哚菁绿荧光成像技术在腹腔镜直肠癌侧方淋巴结清扫中的应用效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 44-47.
[4] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[5] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[6] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[7] 郑民华, 蒋天宇, 赵轩, 马君俊. 中国腹腔镜直肠癌根治术30年发展历程与未来[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 591-595.
[8] 池畔, 黄胜辉. 中国腹腔镜直肠癌根治术30年来的巨大进步[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 596-600.
[9] 李明, 屠松, 闫鹏, 钱军, 高鹏程, 许文山, 杨发英, 胡振涛, 单永玮. 应用前列腺电切镜引导置管治疗直肠低位吻合口漏研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 603-606.
[10] 李玲, 刘亚, 李培玲, 张秀敏, 李萍. 直肠癌患者术后肠道菌群的变化与抑郁症相关性研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 607-610.
[11] 赵梓竣, 兰运升. 改良一针法末端回肠造口术对低位直肠癌保肛术后应激反应及安全性的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 611-614.
[12] 吴胜伟, 王志伟, 陈贵进, 刘序, 吴晓翔. 系膜肥厚低位直肠癌患者改良NOSES Ⅰ式手术的临床效果评价[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 615-618.
[13] 贺斌, 马晋峰. 胃癌脾门淋巴结转移危险因素[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 694-699.
[14] 刘柏隆. 女性压力性尿失禁阶梯治疗之手术治疗方案选择[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 126-126.
[15] 颜世锐, 熊辉. 感染性心内膜炎合并急性肾损伤患者的危险因素探索及死亡风险预测[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 618-624.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?